MARKET

BMRA

BMRA

Biomerica Inc
NASDAQ
0.8320
-0.0580
-6.52%
After Hours: 0.9100 +0.078 +9.38% 18:06 03/28 EDT
OPEN
0.9100
PREV CLOSE
0.8900
HIGH
0.9500
LOW
0.8200
VOLUME
83.98K
TURNOVER
0
52 WEEK HIGH
2.130
52 WEEK LOW
0.7040
MARKET CAP
14.00M
P/E (TTM)
-2.1482
1D
5D
1M
3M
1Y
5Y
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
Biomerica's inFoods IBS technologies will be presented in the IBS Clinical Session at the 2024 Digestive Disease Week (DDW) Annual Meeting in Washington DC. Data from collaborators at the University of Michigan will be shown at DDW. DDW is renowned as the world's premier meeting for digestive disease health care professionals.
Barchart · 1d ago
Weekly Report: what happened at BMRA last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at BMRA last week (0311-0315)?
Weekly Report · 03/18 12:05
Weekly Report: what happened at BMRA last week (0304-0308)?
Weekly Report · 03/11 12:00
Weekly Report: what happened at BMRA last week (0226-0301)?
Weekly Report · 03/04 12:03
12 Health Care Stocks Moving In Friday's After-Market Session
Ainos (NASDAQ:AIMD) stock moved upwards by 54.3% to $1.62 during Friday's after-market session. Aadi Bioscience and Taysha Gene Therapies stock also rose during the session. Losers Healthcare Triangle stock fell 8.1% during the same time period.
Benzinga · 03/01 21:32
12 Health Care Stocks Moving In Thursday's After-Market Session
Cardiff Oncology (NASDAQ:CRDF) shares moved upwards by 28.6% to $2.27 during Thursday's after-market session. The company's, Q4 earnings came out today. Burning Rock Biotech stock rose 10.84% and Kineta shares increased by 20.6%.
Benzinga · 02/29 21:31
Weekly Report: what happened at BMRA last week (0219-0223)?
Weekly Report · 02/26 12:22
More
About BMRA
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.

Webull offers Biomerica Inc stock information, including NASDAQ: BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.